Randomized, Placebo-controlled Trial of an AMPAkine in Major Depressive Disorder

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2005
The purpose of this study is to test a candidate drug, Org 24448,in a phase II clinical trial in adult patients with moderately treatment-resistant unipolar major depressive disorder.
Epistemonikos ID: ef46505fbc1124d41400a3f1f117c3ee7f9ac6b0
First added on: May 04, 2024